All Stories

  1. Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment

    Article • The Breast, August 2025, Elsevier

    Anna Ehinger

  2. Data from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  3. Supplementary Figure S1 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  4. Supplementary Figure S10 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  5. Supplementary Figure S2 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  6. Supplementary Figure S3 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  7. Supplementary Figure S4 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  8. Supplementary Figure S5 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  9. Supplementary Figure S6 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  10. Supplementary Figure S7 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  11. Supplementary Figure S8 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  12. Supplementary Figure S9 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  13. Supplementary Methods 1 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  14. Supplementary Tables 1 from Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • July 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  15. Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort

    Article • Clinical Cancer Research, April 2025, American Association for Cancer Research (AACR)

    Anna Ehinger

  16. A bottom-up initiated digital external quality assessment scheme for the state-of-the-art pathology in Sweden: reduced variability between pathology departments

    Article • Virchows Archiv, February 2025, Springer Science + Business Media

    Anna Ehinger

  17. Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort

    Article • Breast Cancer Research and Treatment, December 2024, Springer Science + Business Media

    Anna Ehinger

  18. The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?

    Article • EClinicalMedicine, December 2024, Elsevier

    Anna Ehinger

  19. Reproducible Reporting of the Collection and Evaluation of Annotations for Artificial Intelligence Models

    Article • Modern Pathology, April 2024, Elsevier

    Anna Ehinger

  20. Training pathologists to assess stromal tumour‐infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research

    Article • Histopathology, March 2024, Wiley

    Anna Ehinger

  21. Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab

    Article • npj Breast Cancer, February 2024, Springer Science + Business Media

    Anna Ehinger

  22. Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms

    Article • Breast Cancer Research, October 2023, Springer Science + Business Media

    Anna Ehinger

  23. Appendix S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  24. Appendix S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  25. Data from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  26. Data from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  27. Data from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  28. Data from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  29. Figure S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  30. Figure S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  31. Figure S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  32. Figure S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  33. Figure S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  34. Figure S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  35. Figure S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  36. Figure S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  37. Figure S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  38. Figure S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  39. Figure S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  40. Figure S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  41. Figure S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  42. Figure S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  43. Figure S5 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  44. Figure S5 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  45. Figure S6 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  46. Figure S6 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  47. Supplementary Legend from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  48. Supplementary Legend from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  49. Table S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  50. Table S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  51. Table S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  52. Table S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  53. Table S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  54. Table S2 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  55. Table S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  56. Table S2 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  57. Table S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  58. Table S3 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  59. Table S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  60. Table S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  61. Table S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  62. Table S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Anna Ehinger

  63. Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

    Article • Modern Pathology, October 2022, Elsevier

    Anna Ehinger

  64. How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer

    Article • Cancers, August 2022, MDPI AG

    Anna Ehinger

  65. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    Article • npj Breast Cancer, August 2022, Springer Science + Business Media

    Anna Ehinger

  66. Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms

    Article • Journal of Medical Imaging, July 2022, SPIE

    Anna Ehinger

  67. Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer

    Article • Cancers, May 2022, MDPI AG

    Anna Ehinger

  68. 52P RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    Article • Annals of Oncology, May 2022, Elsevier

    Anna Ehinger

  69. The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer

    Article • Cancers, February 2022, MDPI AG

    Anna Ehinger

  70. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, December 2021, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

  71. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

    Article • Nature Communications, October 2021, Springer Science + Business Media

    Anna Ehinger

  72. An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Article • Clinical Cancer Research, June 2021, American Association for Cancer Research (AACR)

    Anna Ehinger

  73. Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer

    Article • JNCI Cancer Spectrum, March 2021, Oxford University Press (OUP)

    Anna Ehinger

  74. Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study

    Article • Cancers, March 2021, MDPI AG

    Anna Ehinger

  75. Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

    Article • Breast Cancer Research, February 2021, Springer Science + Business Media

    Anna Ehinger

  76. Molecular analyses of triple-negative breast cancer in the young and elderly

    Article • Breast Cancer Research, February 2021, Springer Science + Business Media

    Anna Ehinger

  77. Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines

    Article • Journal of Clinical Pathology, February 2021, BMJ

    Anna Ehinger

  78. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    Article • Nature Communications, September 2020, Springer Science + Business Media

    Taobo Hu, Dr Elizabeth L Christie, Anna Ehinger

  79. The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome

    Article • EMBO Molecular Medicine, September 2020, EMBO

    Anna Ehinger

  80. Sex differences in oncogenic mutational processes

    Article • Nature Communications, August 2020, Springer Science + Business Media

    Taobo Hu, Dr Elizabeth L Christie, Anna Ehinger

  81. Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival

    Article • Cancer Research, August 2020, American Association for Cancer Research (AACR)

    Anna Ehinger

  82. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

    Article • Nature Communications, July 2020, Springer Science + Business Media

    Anna Ehinger

  83. Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  84. Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer

    Article • npj Breast Cancer, July 2020, Springer Science + Business Media

    Anna Ehinger

  85. Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).

    Article • Journal of Clinical Oncology, May 2020, American Society of Clinical Oncology (ASCO)

    Anna Ehinger

  86. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

  87. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

  88. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger, Dr Stephen M Hewitt

  89. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Article • The Journal of Pathology, April 2020, Wiley

    Anna Ehinger, Khalid El Bairi, Dr Stephen M Hewitt

  90. Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

    Article • Cancer Research, February 2020, American Association for Cancer Research (AACR)

    Anna Ehinger

  91. UK Interdisciplinary Breast Cancer Symposium 2020

    Article • Breast Cancer Research and Treatment, February 2020, Springer Science + Business Media

    Anna Ehinger

  92. Pan-cancer analysis of whole genomes

    Article • Nature, February 2020, Springer Science + Business Media

    Taobo Hu, Anna Ehinger, Professor Daniel S. Brewer, Dr Elizabeth L Christie

  93. The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  94. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

    Article • PLOS One, December 2019, PLOS

    Anna Ehinger

  95. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

    Article • Nature Medicine, September 2019, Springer Science + Business Media

    Anna Ehinger

  96. Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series

    Article • Scientific Reports, August 2019, Springer Science + Business Media

    Anna Ehinger

  97. Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

    Article • Breast Cancer Research and Treatment, August 2019, Springer Science + Business Media

    Anna Ehinger

  98. Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort

    Article • Clinical Cancer Research, July 2019, American Association for Cancer Research (AACR)

    Anna Ehinger

  99. Refinement of breast cancer molecular classification by miRNA expression profiles

    Article • BMC Genomics, June 2019, Springer Science + Business Media

    Anna Ehinger

  100. Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration

    Article • Histopathology, April 2019, Wiley

    Anna Ehinger

  101. Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time

    Article • August 2018, Wiley

    Anna Ehinger

  102. Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors

    Article • June 2018, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  103. Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

    Article • JCO Precision Oncology, March 2018, American Society of Clinical Oncology (ASCO)

    Anna Ehinger

  104. Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  105. Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  106. Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  107. Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  108. Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  109. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative

    Article • BJS, January 2018, Wiley

    Anna Ehinger

  110. Abstracts

    Article • Virchows Archiv, August 2017, Springer Science + Business Media

    Anna Ehinger

  111. Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)

    Article • Cancer Research, February 2017, American Association for Cancer Research (AACR)

    Anna Ehinger

  112. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013

    Article • Acta Oncologica, October 2016, Taylor & Francis

    Anna Ehinger

  113. Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer

    Article • PLOS One, March 2016, PLOS

    Anna Ehinger

  114. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy

    Article • European Journal of Cancer, November 2015, Elsevier

    Anna Ehinger

  115. Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing

    Article • August 2015, Springer Science + Business Media

    Anna Ehinger

  116. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

    Article • Genome Research, May 2015, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  117. Abstract P6-08-43: Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013

    Article • Cancer Research, April 2015, American Association for Cancer Research (AACR)

    Anna Ehinger

  118. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

    Article • Genome Medicine, January 2015, Springer Science + Business Media

    Anna Ehinger

  119. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Article • eLife, October 2014, eLife

    Professor Ming-Qing Du, Anna Ehinger, adrienne Flanagan, Professor Daniel S. Brewer

  120. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Article • Science, July 2014, American Association for the Advancement of Science

    Anna Ehinger, Professor Daniel S. Brewer

  121. Processed pseudogenes acquired somatically during cancer development

    Article • Nature Communications, April 2014, Nature

    Anna Ehinger

  122. Acute pancreatitis evoked by small-cell lung carcinoma metastases and detected by endoscopic ultrasound

    Article • Endoscopy, March 2012, Thieme Publishing Group

    Anna Ehinger

  123. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

    Article • Journal of Ovarian Research, January 2012, Springer Science + Business Media

    Anna Ehinger

  124. G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua

    Article • Molecular Human Reproduction, May 2010, Oxford University Press (OUP)

    Anna Ehinger

  125. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall

    Article • Breast Cancer Research and Treatment, January 2010, Springer Science + Business Media

    Anna Ehinger

  126. Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2

    Article • Molecular Human Reproduction, June 2006, Oxford University Press (OUP)

    Anna Ehinger

  127. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle

    Article • Molecular Human Reproduction, July 2004, Oxford University Press (OUP)

    Anna Ehinger

  128. Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator Receptor

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2001, Endocrine Society

    Anna Ehinger

  129. Breast metastases from pancreatic and ovarian carcinoma

    Article • Diagnostic Cytopathology, August 1999, Wiley

    Anna Ehinger